IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLCGARPConcentrated trader

CIK: 0001844645 | SAN FRANCISCO, CA

Q1 2026 vs Q2 2026 ComparisonProfile

Filing History

QuarterForm TypeHoldingsValueFiledSEC
Q2 2026
13F-HR13$307.8M2026-08-13SEC ↗
Q1 2026
13F-HR13$279.8M2026-05-14SEC ↗
Q4 2025
13F-HR12$258.7M2026-02-13SEC ↗
Q3 2025
13F-HR10$173.0M2025-11-13SEC ↗
Q2 2025
13F-HR12$161.3M2025-08-13SEC ↗
Q1 2025
13F-HR11$123.6M2025-05-14SEC ↗
Q4 2024
13F-HR11$148.1M2025-02-13SEC ↗
Q3 2024
13F-HR11$168.5M2024-11-13SEC ↗
Q2 2024
13F-HR10$130.1M2024-08-13SEC ↗
Q1 2024
13F-HR11$155.6M2024-05-14SEC ↗
Q4 2023
13F-HR13$394.2M2024-02-13SEC ↗
Q3 2023
13F-HR13$250.7M2023-11-13SEC ↗
Q2 2023
13F-HR11$303.3M2023-08-11SEC ↗
Q1 2023
13F-HR11$242.9M2023-05-12SEC ↗
Q4 2022
13F-HR10$230.0M2023-02-13SEC ↗
Q3 2022
13F-HR11$11.1M2022-11-10SEC ↗
Q2 2022
13F-HR11$12.3M2022-08-12SEC ↗
Q1 2022
13F-HR11$11.2M2022-05-13SEC ↗
Q4 2021
13F-HR10$12.0M2022-02-14SEC ↗
Q3 2021
13F-HR9$13.9M2021-11-15SEC ↗
Q2 2021
13F-HR8$15.8M2021-08-16SEC ↗
Q1 2021
13F-HR9$16.8M2021-05-14SEC ↗
Q4 2020
13F-HR9$19.2M2021-02-09SEC ↗